The first radiolabeled 68Ga-FAPI-46 for clinical PET applications using a fully automated iQS-TS synthesis system in Thailand

Authors

  • Natphimol Boonkawin National Cyclotron and PET Centre, Chulabhorn Hospital
  • Chanisa Chotipanich National Cyclotron and PET Centre, Chulabhorn Hospital

Keywords:

68Ga-Fapi-46, Automated synthesis, Fibroblast activation protein (FAP)

Abstract

Background: Gallium-68 labeling of various peptides is now widely used in routine clinical positron emission tomography (PET) applications. We used an automated synthesis system at the National Cyclotron and PET Center of Chulabhorn Hospital to reduce human errors, lower the radiation dosages to operators during synthesis, and establish high product yields. Methods: In this study, we synthesized 68Ga-labeled FAPI-46 peptide using the fully automated iQS-TS theranostics module. The radiosynthesis of 68Ga-Fapi-46 was completed in 15 min, including generator elution and dispensing radiopharmaceuticals. Results: The 68Ga-FAPI-46 radiosynthesis yielded product with 70% ± 2% activity and >95% radiochemical purity. All quality control parameters conformed with the limits prescribed by the European Pharmacopoeia. Conclusion: This study demonstrated successful synthesis of 68Ga-labeled FAPI-46 peptide using the fully automated iQS-TS theranostics module, which produced reliable and reproducible synthetic yields. The 68Ga-FAPI-46 product is of high purity that exceeds minimum recommended requirements.

Downloads

Download data is not yet available.

References

Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteomics Clin Appl. 2014;8(5-6):454-463. https://doi.org/10.1002/prca.201300095

Jansen K, Heirbaut L, Cheng JD, et al. Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold. ACS Med Chem Lett. 2013;4(5):491-496. https://doi.org/10.1021/ml300410d

Lindner T, Loktev A, Giesel F, Kratochwil C, Altmann A, Haberkorn U. Targeting of activated fibroblasts for imaging and therapy. EJNMMI Radiopharm Chem. 2019;4:16. https://doi.org/10.1186/s41181-019-0069-0

Ocak M, Antretter M, Knopp R, et al. Full automation of (68)Ga labelling of DOTA-peptides including cation exchange prepurification. Appl Radiat Isot Data Instrum Methods Use Agric Ind Med. 2010;68(2):297-302. https://doi.org/10.1016/j.apradiso.2009.10.006

Petrik M, Knetsch PA, Knopp R, et al. Radiolabelling of peptides for PET, SPECT and therapeutic applications using a fully automated disposable cassette system. Nucl Med Commun. 2011;32(10):887-895. https://doi.org/10.1097/MNM.0b013e3283497188

European Association of Nuclear Medicine. Gallium Edotreotide Injection Draft Monograph. Pharmeuropa. 2011;23(2):310-313.

Downloads

Published

2021-07-22

How to Cite

1.
Boonkawin N, Chotipanich C. The first radiolabeled 68Ga-FAPI-46 for clinical PET applications using a fully automated iQS-TS synthesis system in Thailand. J Chulabhorn Royal Acad [Internet]. 2021 Jul. 22 [cited 2024 Dec. 22];3(3):180-8. Available from: https://he02.tci-thaijo.org/index.php/jcra/article/view/249531

Issue

Vol. 3 No. 3 (2021): July - September

Section

Research Articles

License

บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของราชวิทยาลัยจุฬาภรณ์

ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับราชวิทยาลัยจุฬาภรณ์ และคณาจารย์ท่านอื่น ในราชวิทยาลัยฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว